Transcatheter arterial chemoembolization combined with PD-1 inhibitors and Lenvatinib for hepatocellular carcinoma with portal vein tumor thrombus

CONCLUSION: A triplet regimen of PTL was safe and well-tolerated as well as exhibited favorable efficacy over the TL regimen for advanced-stage HCC patients with PVTT types I-IV.PMID:38516240 | PMC:PMC10950640 | DOI:10.3748/wjg.v30.i8.843

Source: World Journal of Gastroenterology : WJG - March 22, 2024 Category: Gastroenterology Authors: Hong-Xiao Wu Xiao-Yan Ding Ya-Wen Xu Ming-Hua Yu Xiao-Mi Li Na Deng Jing-Long Chen Source Type: research